Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04224922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04136782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
ClinicalTrials.gov study NCT06318507. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01395056. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03254654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT03316794. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT06401005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05989828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer
ClinicalTrials.gov study NCT06797635. IPD Sharing: YES. Countries: 4. Publications: 0.
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03979508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
ClinicalTrials.gov study NCT05111067. IPD Sharing: NO. Countries: 1. Publications: 0.
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02488967. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03244358. IPD Sharing: NO. Countries: 1. Publications: 0.
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05528133. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases
ClinicalTrials.gov study NCT06210438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy
ClinicalTrials.gov study NCT02362230. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06324240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study
ClinicalTrials.gov study NCT06538896. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06582615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06767527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.